This reported higher prevalence of non-obese NAFLD patients compared with the Western population could be due to the higher proportion of PNPLA3 carriers in Japanese, a gene strongly associated with NAFLD progression [26]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.